2.48

2.48% 0.06

After Hours: 2.48

iBio Inc (IBIO)

Overview News Price History Option Chain Why IBIO Down? Discussions Forecast Stock Split

iBio Inc stock is traded at $2.48, with a volume of 56,888. It is up +2.48% in the last 24 hours and up +13.24% over the past month. iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.

Previous Close:

$2.42

Open:

$2.45

24h Volume:

56,888

Relative Volume:

0.40

Market Cap:

$22.69M

Revenue:

$2.05M

Net Income/Loss:

$-27.28M

P/E Ratio:

-0.4306

EPS:

-5.76

Net Cash Flow:

$-18.89M

1W Performance:

+7.36%

1M Performance:

+13.24%

6M Performance:

+15.89%

1Y Performance:

+78.42%

1-Day Range:

$2.35

$2.55

1-Week Range:

$2.2401

$2.75

52-Week Range:

$1.0214

$4.98

iBio Inc Stock (IBIO) Company Profile

Name

iBio Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

302-355-0650

Address

600 Madison Avenue, Suite 1601, New York, NY

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

IBIO's Discussions on Twitter

Compare IBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IBIO iBio Inc	2.48	22.69M	2.05M	-27.28M	-18.89M	-15.02
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

iBio Inc Stock (IBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-28-24	Initiated	Chardan Capital Markets	Buy
Nov-29-21	Initiated	JMP Securities	Mkt Outperform
Jan-22-21	Initiated	Cantor Fitzgerald	Overweight
Jun-26-20	Initiated	Alliance Global Partners	Buy